Prolaris Q&A with Dr. Brawer
In this video series, Dr. Michael Brawer, Medical Director of Myriad’s Urology Business Unit, addresses nine questions often raised by payers and physicians alike. These questions range from, “Why are long-term studies difficult in prostate cancer?” to “What alternative evidence can be used to validate a prognostic test in prostate cancer?” and “Does Prolaris demonstrate clinical utility?” Click the play button to go to the interactive questionnaire. Once there, click on the square corresponding to your specific question. Stop, pause and move forward at your own pace!